Former Johnson & Johnson executive joins Maitri Health advisory board
by CM Staff
Bridget Ross serves as a Board Director for LeMaitre Vascular Inc. and as a mentor for early stage MedTech companies through MassMEDIC and the Canadian Consulate Technology Accelerator, in Boston, MA.
VANCOUVER — On Mar. 23, Maitri Health Technologies Corp., a platform for healthcare supply security, announced the appointment of Bridget Ross to its Advisory Board.
Ms. Ross is currently CEO of ChroniSense Medical, Ltd., an Israel-based MedTech company and maker of wearable, medical-grade disease management devices. Ms. Ross serves as a Board Director for LeMaitre Vascular Inc. and as a mentor for early stage MedTech companies through MassMEDIC and the Canadian Consulate Technology Accelerator, in Boston, MA. For three decades, she held executive roles at Johnson & Johnson (J&J).
“Bridget brings an unmatched level of experience and success to Maitri’s extended team,” said Andrew Morton, CEO of Maitri. “Maitri is uniquely positioned to modernize healthcare systems for governments, healthcare systems and businesses to function well beyond the pandemic. Bridget’s counsel and insights on product development will be invaluable as we continue to evolve and execute our integrated PPE and technology strategy.”
Ms. Ross was previously President of the Global Medical Group at Henry Schein, where she led the growth strategy for a US$2.4 billion global business. At J&J, she was appointed Vice President, Commercial Operations of its North American Medical Device Sector, after previous roles as Global President at two J&J subsidiaries, leading product innovation and sales.
A graduate of the University of Alberta, Ms. Ross also previously served as a Health Sector Advisory Council Member at Duke University in North Carolina. Along with an Advisory Board, Maitri’s Board of Directors includes a former Canadian Minister of Health and a former chief digital officer of Bayer Inc. as well.
